Education
About Us
Working with TipRanks
Follow Us
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
Total Valuation
Hepion Pharmaceuticals has a market cap or net worth of $720.46K. The enterprise value is -$1.25M.
Market Cap$720.46K
Enterprise Value-$1.25M
Share Statistics
Hepion Pharmaceuticals has 11,620,317 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,620,317
Owned by Insiders―
Owned by Institutions8.11%
Financial Efficiency
Hepion Pharmaceuticals’s return on equity (ROE) is -3.10 and return on invested capital (ROIC) is -147.41%.
Return on Equity (ROE)-3.10
Return on Assets (ROA)-2.70
Return on Invested Capital (ROIC)-147.41%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-376.27K
Employee Count22
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Hepion Pharmaceuticals is ―. Hepion Pharmaceuticals’s PEG ratio is 0.00069.
PE Ratio―
PS Ratio0.00
PB Ratio0.21
Price to Fair Value0.21
Price to FCF-0.17
Price to Operating Cash Flow-0.18
PEG Ratio0.00069
Income Statement
In the last 12 months, Hepion Pharmaceuticals had revenue of 0.00 and earned -8.28M in profits. Earnings per share was -0.88.
Revenue0.00
Gross Profit0.00
Operating Income-4.16M
Pretax Income-8.28M
Net Income-8.28M
EBITDA-4.16M
Earnings Per Share (EPS)-0.88
Cash Flow
In the last 12 months, operating cash flow was -3.27M and capital expenditures 0.00, giving a free cash flow of -3.27M billion.
Operating Cash Flow-3.27M
Free Cash Flow-3.27M
Free Cash Flow per Share-0.28
Dividends & Yields
Hepion Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta>-0.01
52-Week Price Change-94.04%
50-Day Moving Average0.05
200-Day Moving Average0.06
Relative Strength Index (RSI)57.68
Average Volume (3m)24.29K
Important Dates
Hepion Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Hepion Pharmaceuticals as a current ratio of 10.25, with Debt / Equity ratio of 2.03%
Current Ratio10.25
Quick Ratio10.25
Debt to Market Cap0.10
Net Debt to EBITDA0.43
Interest Coverage Ratio170.60
Taxes
In the past 12 months, Hepion Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hepion Pharmaceuticals EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 0.37.
EV to Sales0.00
EV to EBITDA0.29
EV to Free Cash Flow0.37
EV to Operating Cash Flow0.37
Balance Sheet
Hepion Pharmaceuticals has $1.83M in cash and marketable securities with $54.07K in debt, giving a net cash position of $1.77M billion.
Cash & Marketable Securities$1.83M
Total Debt$54.07K
Net Cash$1.77M
Net Cash Per Share$0.15
Tangible Book Value Per Share$0.28
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Hepion Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―